American Express (AXP) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

30.01.26 16:00 Uhr

Werte in diesem Artikel
Aktien

290,30 EUR -9,10 EUR -3,04%

Indizes

PKT PKT

48.643,3 PKT -428,2 PKT -0,87%

18.642,7 PKT 132,3 PKT 0,71%

3.427,2 PKT -14,1 PKT -0,41%

6.921,1 PKT -47,9 PKT -0,69%

American Express (AXP) reported $18.98 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 10.5%. EPS of $3.53 for the same period compares to $3.04 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $18.82 billion, representing a surprise of +0.84%. The company delivered an EPS surprise of -0.28%, with the consensus EPS estimate being $3.54.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how American Express performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total Card Member loans: $151.83 billion versus $151.12 billion estimated by two analysts on average.Risk-Based Capital Ratios - Basel III - Common Equity Tier 1/Risk Weighted Assets: 10.5% versus the two-analyst average estimate of 10.4%.Commercial Services - Card Member loans - Total loans: $30.83 billion compared to the $30.60 billion average estimate based on two analysts.International Card Services - Card Member loans - consumer and small business - Total loans: $20.83 billion compared to the $19.79 billion average estimate based on two analysts.Network volumes: $506.20 billion versus the two-analyst average estimate of $502.57 billion.Book value per common share: $46.45 compared to the $46.17 average estimate based on two analysts.U.S. Consumer Services - Card Member loans - Total loans: $100.17 billion versus the two-analyst average estimate of $100.73 billion.Total non-interest revenues: $14.46 billion versus $14.33 billion estimated by five analysts on average.Net Interest Income: $4.52 billion versus the five-analyst average estimate of $4.51 billion.Non-interest revenues- Discount revenue: $9.88 billion versus $9.83 billion estimated by three analysts on average.Non-interest revenues- Net card fees: $2.63 billion compared to the $2.63 billion average estimate based on three analysts.Non-interest revenues- Service fees and other revenue: $1.95 billion compared to the $1.89 billion average estimate based on three analysts.View all Key Company Metrics for American Express here>>>Shares of American Express have returned -3.1% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.See Our Newest 5 Stocks Set to Double Picks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Express Company (AXP): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: American Express und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf American Express

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf American Express

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu American Express Co.

Wer­bung

Analysen zu American Express Co.

DatumRatingAnalyst
01.06.2021American Express overweightJP Morgan Chase & Co.
08.07.2019American Express BuyDeutsche Bank AG
25.04.2019American Express overweightMorgan Stanley
19.10.2018American Express Market PerformBMO Capital Markets
12.02.2018American Express buyNomura
DatumRatingAnalyst
01.06.2021American Express overweightJP Morgan Chase & Co.
08.07.2019American Express BuyDeutsche Bank AG
25.04.2019American Express overweightMorgan Stanley
19.10.2018American Express Market PerformBMO Capital Markets
12.02.2018American Express buyNomura
DatumRatingAnalyst
11.01.2018American Express Equal WeightBarclays Capital
27.04.2017American Express NeutralInstinet
21.04.2017American Express NeutralGoldman Sachs Group Inc.
21.04.2016American Express NeutralD.A. Davidson & Co.
11.03.2016American Express Equal WeightBarclays Capital
DatumRatingAnalyst
22.01.2016American Express UnderperformOppenheimer & Co. Inc.
22.01.2016American Express UnderperformRBC Capital Markets
26.10.2015American Express SellUBS AG
17.04.2015American Express UnderperformRBC Capital Markets
07.04.2015American Express UnderperformOppenheimer & Co. Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für American Express Co. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen